Dr. Reddy's launches generic of AbbVie's Zemplar

Dr. Reddy’s Laboratories (RDY) announced that it has launched Paricalcitol Capsules, a therapeutic equivalent generic version of Zemplar in the U.S. market on June 24, 2014, following the approval by the FDA. Zemplar is made by AbbVie (ABBV).

Advertisement